So much for going offshore to get an approval. Kind of like how LL was treated in the Philippines and India. They still won't make a public statement in PI about the effectiveness of LL. India ran from CYDY when they attempted to do a trial there. I think EFDA had fingerprints on those as well.

As distasteful as it sounds, IMO the only way we get this drug approved is partnering with one of EFDA's buddies to get us across the goal line. Follow the money.